Predictors of success in smoking cessation among Italian adults motivated to quit

Journal of Substance Abuse Treatment

Volumn 44, Issue 5, 2013, Pages 534-540

  Iliceto, Paolo ^a   Fino, Emanuele ^a   Pasquariello, Stefania ^a   D'Angelo Di Paola, Maria E ^a   Enea, Domenico ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Age of onset; Bupropion; Counseling; Fagerstr m test; Smoking cessation; Tobacco addiction; Varenicline

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ADULT; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GROUP THERAPY; HEALTH PROGRAM; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; AGE FACTORS; AGE OF ONSET; BENZAZEPINES; BUPROPION; COGNITIVE THERAPY; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MOTIVATION; MULTIVARIATE ANALYSIS; PSYCHOTHERAPY, GROUP; QUINOXALINES; SEX FACTORS; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84875081410     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.12.004     Document Type: Article

References (61)

1. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review 1977, 8:191-215. 10.1037/0033-295X.84.2.191.
2. Beck A.T., Steer R.A. Beck Depression Inventory 1978, Center for Cognitive Therapy, Philadelphia.
3. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., Jacob P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology and Therapeutics 2006, 79:480-488. 10.1016/j.clpt.2006.01.008.
4. Braslau N., Peterson E.L. Smoking initiation in young adults: Age at initiation of cigarette smoking and other suspected influences. American Journal of Public Health 1996, 86:214-220. 10.2105/AJPH.86.2.214.
5. Breslau N., Kilbey M.M., Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. American Journal of Psychiatry 1992, 149:464-469.
6. Cavuto S., Bravi F., Grassi M.C., Apolone G. Propensity score for the analysis of observational data: An introduction and an illustrative example. Drug Development Research 2006, 67:208-216. 10.1002/ddr.20079.
7. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 2004, 72:712-722. 10.1037/0022-006X.72.4.712.
8. Chatkin J.M., Mariante de Abreu C., Haggstram F.M., Wagner M.B., Fritscher C.C. Abstinence rates and predictors of outcome for smoking cessation: Do Brazilian smokers need special strategies?. Addiction 2004, 99:778-784. 10.1111/j.13600443.2004.00755.x.
9. Cowling D.W., Johnson T.P., Holbrook B.C., Warnecke R.B., Tang H. Improving the self reporting of tobacco use: Results of a factorial experiment. Tobacco Control 2003, 12:178-183. 10.1136/tc.12.2.178.
10. Dale L.C., Glover E.D., Sachs D.P., Schroeder D.R., Offord K.P., Croghan I.T., et al. Bupropion for smoking cessation: Predictors of successful outcome. Chest 2001, 119:1357-1364. 10.1378/chest.119.5.1357.
11. Derogatis L.R. Symptom Checklist-90-R: Administration, scoring, and procedures manual 1994, National Computer Systems, Minneapolis, MN. 3rd ed., 10.1002/9780470479216.corpsy0970.
12. Ding D., Hovell M.F., Ji M., Hofstetter C.R., Zheng P., Fu H., et al. Employment and social "determinants" of smoking in urbanizing China: A representative survey. Nicotine & Tobacco Research 2009, 11:779-784. 10.1093/ntr/ntp060.
13. Dorner T., Tröstl A., Womastek I., Groman E. Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program. Nicotine & Tobacco Research 2011, 13:1068-1075. 10.1093/ntr/ntr179.
14. Etter J.F. A comparison of the content- construct- and predictive validity of the cigarette dependence scale and the Fageström test for nicotine dependence. Drug and Alcohol Dependence 2005, 77:259-268. 10.1016/j.drugalcdep. 2004.08.015.
15. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 1978, 3:235-341.
16. Ferketich A.D., Gallus S., Iacobelli N., Zuccaro P., Colombo P., La Vecchia C. Smoking in Italy 2007, with a focus on the young. Tumori 2008, 94:793-797. 10.1700/396.4657.
17. Fiore F.C., Jaén C.R., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J. Treating tobacco use and dependence: 2008 update. Clinical practice guideline 2008, May, U.S. Department of Health and Human Services Public Health Service, Rockville, MD.
18. Fiore M.C., Theobald C. Treating tobacco use and dependence: A call to arms for Italian physicians. Tabaccologia 2009, 2-3:6-8.
19. Frikart M., Etienne S., Cornuz J., Zellweger J.P. Five-day plan for smoking cessation using group behaviour therapy. Swiss Medical Weekly 2003, 133:39-43.
20. Gallus S., Muttarak R., Martinez-Sanchez J.M., Zuccaro P., Colombo P., La Vecchia C. Smoking prevalence and smoking attributable mortality in Italy, 2010. Preventive Medicine 2011, 52:434-438. 10.1016/j.ypmed.2011.03.011.
21. Gariti P., Alterman A.I., Ehrman R., Mulvaney F.D., O'Brien C.P. Detecting smoking following smoking cessation treatment. Drug and Alcohol Dependence 2002, 65:191-196. 10.1016/S0376-8716(01)00162-4.
22. Grassi M.C., Enea D., Ferketich A.K., Lu B., Nencini P. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcome sat 1 year. Nicotine & Tobacco Research 2009, 11:114-121. 10.1093/ntr/ntp110.
23. Grassi M.C., Enea D., Ferketich A.K., Lu B., Pasquariello S., Nencini P. Effectiveness of varenicline for smoking cessation: A 1-year follow-up study. Journal of Substance Abuse Treatment 2011, 41:64-70. 10.1016/j.jsat.2011.01.014.
24. Grassi M.C., Enea D., Marchetti R., Caricati A.M., Nencini P. Combined counseling and bupropion therapy for smoking cessation: Identification of outcome predictors. Drug Development Research 2006, 67:271-279. 10.1002/ddr.20085.
25. Gritz E.R., Carr C.R., Marcus A.C. The tobacco withdrawal syndrome in unaided quitters. British Journal of Addiction 1991, 86:57-69. 10.1111/j.1360-0443.1991.tb02629.x.
26. Harrison L., Hughes A. Introduction-The validity of selfreported drug use: Improving the accuracy of survey estimates. NIDA Research Monographs 1997, 167:1-16. 10.1007/s11414-008-9162-y.
27. Hughes J.R. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research 2007, 9:315-327. 10.1080/14622200701188927.
28. Hurt R.D., Wolter T.D., Rigotti N., Hays J.T., Niaura R., Durcan M.J., et al. Bupropion for pharmacologic relapse prevention to smoking: Predictors of outcome. Addictive Behaviors 2002, 27:493-507. 10.1016/S03064603(01)00188-5.
29. Hymowitz N., Cummings K.M., Hyland A., Lynn W.R., Pechacek T.F., Hartwell T.D. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tobacco Control 1997, 6:S57-S62. 10.1136/tc.6.suppl_2.S57.
30. Khuder S.A., Dayal H.H., Mutgi A.B. Age at smoking onset and its effect on smoking cessation. Addictive Behaviors 1999, 24:673-677. 10.1016/S03064603(98)00113-020.
31. Killen J.D., Fortmann S.P., Murphy G.M., Hayward C., Arredondo C., Cromp D., et al. Extended treatment with bupropion SR for cigarette smoking cessation. Journal of Consulting and Clinical Psychology 2006, 74:286-294. 10.1037/0022-006X.74.2.286.
32. Lancaster T., Stead L., Silagy C., Sowden A. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library. British Medical Journal 2000, 321:355-358. 10.1136/bmj.321.7257.355.
33. Leischow S.J., Valente S.N., Hill A.L., Otte P.S., Aickin M., Holden T., et al. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence. Experimental and Clinical Psychopharmacology 1997, 5:54-64. 10.1037/1064-1297.5.1.54.
34. Littlefield A.K., Sher K.J. Smoking desistance and personality change in emerging and young adulthood. Nicotine & Tobacco Research 2012, 14:338-342. 10.1093/ntr/ntr219.
35. Mangiaracina G. Curare il Fumo. Treating tobacco use 2003, EDUP, Rome.
36. Maxwell C. Sensitivity and accuracy of the visual analogue scale: A psycho-physical classroom experiment. British Journal of Clinical Pharmacology 1978, 6:15-24.
37. McFarland J.W., Folkenberg E.J. How to stop smoking in five days 1964, Prentice-Hall Inc, Englewood Cliffs, NJ.
38. McLellan A.T., O'Brien C.P., Lewis D., Kleber H.D. Drug addiction as a chronic medical illness: Implications for treatment, insurance and evaluation. Journal of the American Medical Association 2000, 284:1689-1695. 10.1001/jama.284.13.1689.
39. Nicholson A.N. Visual Analogue Scales and drug effects in man. British Journal of Clinical Pharmacology 1978, 6:3-4.
40. Nides M. Update on pharmacologicoptions for smoking cessationtreatment. American Journal of Medicine 2008, 121:S20-S31. 10.1016/j.amjmed.2008.01.016.
41. Nides M., Glover E.D., Reus V.I., Christen A.G., Maker B.J., Billing C.B., et al. Varenicline versus bupropion SR or placebo for smoking cessation: A pooled analysis. American Journal of Health Behavior 2008, 32:664-675. 10.5993/AJHB.32.6.
42. OssFAD.Osservatorio Fumo, Alcol e Droga Rapporto annuale sul fumo 2010. Indagine DOXA. IstitutoSuperiore di Sanità Retrieved May 25, 2012 from. http://www.iss.it/fumo/rann/cont.php?id=195&lang=1&tipo=3.
43. Pan Z. Socioeconomic predictors of smoking and smoking frequency in urban China: Evidence of smoking as a social function. Health Promotion International 2004, 19:309-315. 10.1093/heapro/dah304.
44. Patrick D.L., Cheadle A., Thompson D.C., Diehr P., Koepsell T., Kinne S. The validity of self-reported smoking: A review and meta-analysis. American Journal of Public Health 1994, 84:1086-1093. 10.2105/AJPH.84.7.1086.
45. Perkins K.A., Donny E., Caggiula A.R. Sex differences in nicotine effects and self-administration: Review of human and animal evidence. Nicotine & Tobacco Research 1999, 1:301-315. 10.1080/14622299050011431.
46. Perkins K.A., Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research 2008, 10:1245-1250. 10.1080/14622200802097506.
47. Picardi A., Bertoldi S., Morosini P. Association between the engagement of relatives in a behavioural group intervention for smoking cessation and higher quit rates at 6-, 12- and 24-month follow-ups. European Addiction Research 2002, 8:109-117. 10.1159/000059379.
48. Ravva P., Gastonguay M.R., French J.L., Tensfeldt T.G., Faessel H.M. Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation. Clinical Pharmacology and Therapeutics 2010, 87:336-344. 10.1038/clpt.2009.282.
49. Rigotti N.A. Treatment of tobacco use and dependence. The New England Journal of Medicine 2002, 346:506-512. 10.1056/NEJM200207253470416.
50. Romand R., Gourgou S., Sancho-Garnier H. A randomized trial assessing the five-day plan for smoking cessation. Addiction 2005, 100:1546-1554. 10.1111/j.13600443.2005.01215.x.
51. Schnoll R.A., Patterson F. Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. Drug and Alcohol Dependence 2009, 104:S94-S99. 10.1016/j.drugalcdep. 2008.11.012.
52. Schuurmans M.M., Bolliger C.T. Smoking cessation strategies for real-life situations?. Swiss Medical Weekly 2003, 133:29-30.
53. Swan G.E., Jack L.M., Curry S., Chorost M., Javitz H., McAfee T., et al. 22 bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine & Tobacco Research 2003, 6:911-921. 10.1080/14622200310001646903 ->.
54. Taioli E., Wynder E.L. Effect of the age at which smoking begins on frequency of smoking in adulthood. The New England Journal of Medicine 1991, 325:968-969. 10.1056/NEJM199109263251318.
55. Taylor A.E., Johnson D.C., Kazemi H. Environmental tobacco smoke and cardiovascular disease: A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation 1992, 86:699-702.
56. Thompson D.S., Wilson T.R. Discontinuance of cigarette smoking: "natural" and with "therapy." A ten-week and ten-month follow-up study of 298 adult participants in a five-day plan to stop smoking. Journal of the American Medical Association 1966, 196:1048-1052. 10.1001/jama.1966.03100250058020.
57. Tønnesen P. Smoking cessation: How compelling is the evidence? A review. Health Policy 2009, 91:S15-S25. 10.1016/S0168-8510(09)70004-1.
58. Unger J.B., Cruz T., Shakib S., Mock J., Shields A., Baezconde-Garbanati L., et al. Exploring the cultural context of tobacco use: A transdisciplinary framework. Nicotine & Tobacco Research 2003, 5:S101-S117. 10.1080/14622200310001625546.
59. Welch P., Poulton R. Personality influences on change in smoking behavior. Health Psychology 2009, 28:292-299. 10.1037/a0013471.
60. World Health Organization WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco 2011, Who Press, Geneva, Retrieved May 25, 2012, from. http://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf.
61. Zhu S.H., Anderson C.M., Tedeschi G.J., Rosbrook B., Johnson C.E., Byrd M., et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New England Journal of Medicine 2002, 347:1087-1093. 10.1056/NEJMs/a020660.